Morphine-induced place preference: Involvement of cholinergic receptors of the ventral tegmental area

European Journal of Pharmacology

Volumn 562, Issue 1-2, 2007, Pages 92-102

  Rezayof, Ameneh ^a   Nazari Serenjeh, Farzaneh ^a   Zarrindast, Mohammad Reza ^b,c,d   Sepehri, Houri ^a   Delphi, Ladan ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

^d INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

Author keywords

(Rat); Atropine; Conditioned place preference; Mecamylamine; Morphine; Nicotine; Physostigmine; Ventral tegmental area

Indexed keywords

ATROPINE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; MECAMYLAMINE; MORPHINE SULFATE; NICOTINE; PHYSOSTIGMINE;

ANIMAL EXPERIMENT; ARTICLE; AVERSIVE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; VENTRAL TEGMENTUM;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; ATROPINE; BEHAVIOR, ANIMAL; CHOLINESTERASE INHIBITORS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SUBCUTANEOUS; MALE; MECAMYLAMINE; MORPHINE; MOTOR ACTIVITY; MUSCARINIC ANTAGONISTS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PHYSOSTIGMINE; RATS; RATS, WISTAR; RECEPTORS, CHOLINERGIC; VENTRAL TEGMENTAL AREA;

EID: 33947502340     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.081     Document Type: Article

References (76)

1. Auerbach J.M., and Segal M. Muscarinic receptors mediating depression and long-term potentiation in rat hippocampus. J. Physiol. (Lond.) 492 (1996) 479-493
2. Basile A.S., Fedorova I., Zapata A., Liu X., Shippenberg T., Duttaroy A., et al. Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11452-11457
3. Beilin B., Nemirovsky A.Y., Zeidel A., Maibord E., Zelman V., and Katz R.L. Systemic physostigmine increases the antinociceptive effect of spinal morphine. Pain 70 (1997) 217-221
4. Belzung C., and Barreau S. Differences in drug-induced place conditioning between BAlB/C and C57B1/6 mice. Pharmacol. Biochem. Behav. 65 (2000) 419-423
5. Blomqvist O., Nissbrandt H., Engel J.A., and Soderpalm B. The mesolimbic dopamine-activating effects of ethanol are antagonized by mecamylamine. Eur. J. Pharmacol. 249 (1993) 207-213
6. Boccia M.M., Acosta G.B., and Baratti C.M. Memory improving actions of gabapentin in mice: possible involvement of central muscarinic cholinergic mechanism. Neurosci. Lett. 311 (2001) 153-156
7. Calabresi P., Lacey M.G., and North R.A. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br. J. Pharmacol. 98 (1989) 135-140
8. Carr G.D., and White N.M. Conditioned place preference from intraaccumbens but not intra-caudate amphetamine injections. Life Sci. 33 (1983) 2551-2557
9. Cervo L., and Samanin R. Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res. 673 (1995) 242-250
10. Chintoh A., Fulton J., Koziel N., Aziz M., Sud M., and Yeomans J.S. Role of cholinergic receptors in locomotion induced by scopolamine and oxotremorine-M. Pharmacol. Biochem. Behav. 76 (2003) 53-61
11. Clarke P.B.S., and Fibiger H.C. Apparent absence of nicotine-induced conditioned place preference in rats. Psychopharmacology 92 (1987) 84-88
12. Corrigall W.A. Nicotine self-administration in animals as a dependence model. Nicotine Tob. Res. 1 (1999) 11-20
13. Corrigall W.A., Coen K.M., and Adamson K.L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 653 (1994) 278-284
14. Dani J.A., Ji D., and Zhou F.M. Synaptic plasticity and nicotine addiction. Neuron 31 (2001) 349-352
15. David V., Besson M., Changeux J.-P., Cranon S., and Cazala P. Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors. Neuropharmacology 50 (2006) 1030-1040
16. De Fonseca F.R.D., Rubio P., Martin-Caldon J.L., Caine S.B., Koob G.F., and Navarro M. The dopamine receptor agonist 7-OH-DPATmodulates the acquisition and expression of morphine-induced place preference. Eur. J. Pharmacol. 274 (1995) 47-55
17. Dewey S.L., Brodie J.D., Gerasimov B.M., Horan B., Gardner E.L., and Ashby C.R. A pharmacologic strategy for the treatment of nicotine addiction. Synapse 31 (1999) 76-86
18. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur. J. Pharmacol. 393 (2000) 295-314
19. Ericson M., Blomqvist O., Engel J.A., and Soderpalm B. Voluntary ethanol intake in the rat and the associated acccumbal dopamine overflow are blocked by ventral tegmental mecamylamine. Eur. J. Pharmacol. 358 (1998) 189-196
20. Ferrari R., Le Novere N., Picciotto M.R., Changeux J.P., and Zoli M. Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. Eur. J. Neurosci. 15 (2002) 1810-1818
21. Gholami A., Haeri-Rohani A., Sahraie H., and Zarrindast M.R. Nitric oxide mediation of morphine-induced place preference in the nucleus accumbens of rat. Eur. J. Pharmacol. 449 (2002) 269-277
22. Greenfield S.A. A non-cholinergic action of acetylcholinesterase (AChE) in the rat brain: from neuronal secretion to the generation of movement. Cell. Mol. Neurobiol. 11 (1991) 55-77
23. Grillner P., Bonci A., Svensson T.H., Bernardi G., and Mercuri N.B. Presynaptic muscarinic (M3) receptors reduce excitatory transmission in dopamine neurons of the rat mesencephalon. Neuroscience 91 (1999) 557-565
24. Gronier B., and Rasmussen K. Activation of midbrain presumed dopaminergic neurons by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat. Br. J. Pharmacol. 124 (1998) 455-464
25. Gronier B., Perry K.W., and Rasmussen K. Activation of the mesocorticolimbic dopaminergic system by stimulation of muscarinic cholinergic receptors in the ventral tegmental area. Psychopharmacology 147 (2000) 347-355
26. Hsu K.S., Huang C.C., and Gean P.W. Muscarinic depression of excitatory synaptic transmission mediated by the presynaptic M3 receptors in the rat striatum. Neurosci. Lett. 197 (1995) 141-144
27. Hsu E.H., Schroeder J.P., and Packard M.G. The amygdala mediates memory consolidation for an amphetamine conditioned place preference. Behav. Brain Res. 129 (2002) 93-100
28. Hyman S.E., and Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev., Neurosci. 2 (2001) 695-703
29. Jones S., Sudweeks S., and Yakel J.L. Nicotinic receptors in the brain: correlating physiology with function. Trends Neurosci. 22 (1999) 555-561
30. Jorenby D.E., Steinpreis R.E., Sherman J.E., and Baker T.B. Aversion instead of preference learning indicated by nicotine place conditioning in rats. Psychopharmacology 101 (1990) 533-538
31. Klink R., de Kerchove D.E.A., Zoli M., and Changeux J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 21 (2001) 1452-1463
32. Kobayashi R.M., Brownstein M., Saavedra J.M., and Palkovits M. Choline acetyltransferase content in discrete regions of the rat brain. J. Neurochem. 24 (1975) 637-640
33. Laviolette S.R., and Van der Kooy D. Blockade of mesolimbic dopamine transmission dramatically increase sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol. Psychiatry 8 (2003) 50-59
34. Laviolette S.R., and Van der Kooy D. The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the alpha7-subunit-containing nicotinic acetylcholine receptor. Psychopharmacology 166 (2003) 306-313
35. Levin E.D., Briggs S.J., Christopher N.C., and Auman T. Working memory performance and cholinergic effects in the ventral tegmental area and substantia nigra. Brain Res. 657 (1994) 165-170
36. Lu L., Xu N.J., Ge X., Yue W., Su W.J., and Pei G. Reactivation of morphine conditioned place preference by drug priming: role of environmental cues and sensitization. Psychopharmacology 159 (2002) 125-132
37. Mansvelder H.D., Keath J.R., and McGehee D.S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33 (2002) 905-919
38. Manzanedo C., Aguilar M.A., Rodriguez-arias M., and Minarro J. Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav. Brain Res. 121 (2001) 189-197
39. McBride W.J., Murphy J.M., and Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav. Brain Res. 101 (1999) 129-152
40. McGehee D.S., and Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57 (1995) 521-546
41. Miller A.D., and Blaha C.D. Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat. Eur. J. Neurosci. 21 (2005) 1837-1846
42. Miller A.D., Forster G.L., Yeomans J.S., and Blaha C.D. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat. Neuroscience 136 (2005) 531-538
43. Olmstead M.C., and Franklin B.J. The development of a conditioned place preference to morphine: effects of lesions of various CNS sites. Behav. Neurosci. 111 (1997) 1313-1323
44. Olmstead M.C., and Franklin B.J. The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Behav. Neurosci. 111 (1997) 1324-1334
45. Parker L.A. Place conditioning in a three- or four-choice apparatus: role of stimulus novelty in drug-induced place conditioning. Behav. Neurosci. 106 (1992) 294-306
46. Paxinos G., and Watson C. The Rat Brain in Stereotaxin Coordinates. 2nd ed. (1986), Academic Press, Pub., New York
47. Pidoplichko V.I., DeBiasi M., Williams J.T., and Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390 (1997) 401-404
48. Power A.E., Vazdarjanova A., and McGaugh J.L. Muscarinic cholinergic influences in memory consolidation. Neurobiol. Learn. Mem. 80 (2003) 178-193
49. Rada P.V., Mark G.P., Yeomans J.J., and Hoebel B.G. Acetylcholine release in ventral tegmental area by hypothalamic self-stimulation, eating, and drinking. Pharmacol. Biochem. Behav. 65 (2000) 375-379
50. Rezayof A., Zarrindast M.R., Sahraei H., and Haeri-Rohani A. Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Pharmacol. Biochem. Behav. 74 (2002) 187-197
51. Rezayof A., Zarrindast M.R., Sahraei H., and Haeri-Rohani A. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. J. Psychopharmacol. 17 (2003) 415-423
52. Rezayof A., Zatali H., Haeri-Rohani A., and Zarrindast M.R. Dorsal hippocampal muscarinic and nicotinic receptors are involved in mediating morphine reward. Behav. Brain Res. 166 (2006) 281-290
53. Rezayof A., Razavi S., Haeri-Rohani H., Rassouli Y., and Zarrindast M.R. GABA(A) receptors of hippocampal CA1 regions are involved in the acquisition and expression of morphine-induced place preference. Eur. Neuropsychopharmacol. 17 (2007) 24-31
54. Sara S.J. Retrieval and reconsolidation: toward a neurobiology of remembering. Learn. Mem. 7 (2000) 73-84
55. Sukhotina I.A. Morphine withdrawal-facilitated aggression is attenuated by morphine-conditioned stimuli. Pharmacol. Biochem. Behav. 68 (2001) 93-98
56. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comparative review of drug effects, recent progress and new issues. Prog. Neurobiol. 56 (1998) 613-672
57. Tzschentke T.M., and Schmidt W.J. N-Methyl-d-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci. Lett. 193 (1995) 37-40
58. Tzschentke T.M., and Schmidt W.J. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behav. Brain Res. 84 (1997) 99-107
59. Vilaro M.T., Palacios J.M., and Mengod G. Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neurosci. Lett. 114 (1990) 154-159
60. Walker D.L., McGlynn T., Grey C., Ragozzino M., and Gold P.E. Naloxone modulates the behavioral effects of cholinergic agonists and antagonists. Psychopharmacology 105 (1991) 57-62
61. Weiner D.M., Levey A.I., and Brann M.R. Expression of muscarinic acetylcholine and dopamine receptors mRNAs in rat basal ganglia. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 7050-7054
62. White N.M., and Carr G.D. The conditioned place preference is affected by two independent reinforcement processes. Pharm. Biochem. Behav. 23 (1985) 37-42
63. Wickegren I. Teaching the brain to take drugs. Science 280 (1998) 2045-2046
64. Wonnacott S., Sidhpura N., and Balfour D.J. Nicotine: from molecular mechanisms to behaviour. Curr. Opin. Pharmacol. 5 (2005) 53-59
65. Wooltorton J.R., Pidoplichko V.I., Broide R.S., and Dani J.A. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J. Neurosci. 23 (2003) 3176-3185
66. Yeomans J., and Baptista M. Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward. Pharmacol. Biochem. Behav. 57 (1997) 915-921
67. Yeomans J., Mathur A., and Tampakeras M. Rewarding brain stimulation: role of tegmental cholinergic neurons that active dopamine neurons. Behav. Neurosci. 107 (1993) 1077-1087
68. Yeomans J., Forster G., and Blaha C. M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci. 68 (2001) 2449-2456
69. Zachariou V., Caldarone B.J., Weathers-Lowin A., George T.P., Elsworth J.D., Roth R.H., et al. Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology 24 (2001) 576-589
70. Zarrindast M.R., and Jamshidzadeh A. Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats. Br. J. Pharmacol. 105 (1992) 675-678
71. Zarrindast M.R., Lahiji P., Shafaghi B., and Sadegh M. Effects of GABAergic drugs on physostigmine-induced improvement in memory acquisition of passive avoidance learning in mice. Gen. Pharmacol. 31 (1998) 81-86
72. Zarrindast M.R., Bahreini T., and Adl M. Effect of imipramine on the expression and acquisition of morphine-induced conditioned place preference in mice. Pharmacol. Biochem. Behav. 73 (2000) 941-949
73. Zarrindast M.R., Faraji N., Rostami P., Sahraei H., and Ghoshouni H. Crosstolerance between morphine- and nicotine-induced conditioned place preference in mice. Pharmacol. Biochem. Behav. 74 (2003) 363-369
74. Zarrindast M.R., Rezayof A., Sahraei H., Haeri-Rohani A., and Rassouli Y. Involvement of dopamine D1 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Brain Res. 965 (2003) 212-221
75. Zarrindast M.R., Fattahi Z., Rostami P., and Rezayof A. Role of the cholinergic system in the rat basolateral amygdala on morphine-induced conditioned place preference. Pharmacol. Biochem. Behav. 82 (2005) 1-10
76. Zarrindast M.R., Massoudi R., Sepehri H., and Rezayof A. Involvement of GABAB receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. Physiol. Behav. 87 (2006) 31-38